Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing

Award Number: R44DA057185
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2022
PERIOD OF PERFORMANCE END DATE: 07/31/2025

Group Awards By:

View Award Description

COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing - ABSTRACT Methadone maintenance reduces and/or eliminates the use of opioids, reduces the death rates and criminality associated with opioid use, and allows patients to improve their health and social productivity. In addition, enrollment in Methadone Maintenance Treatment (MMT) can reduce the transmission of infectious diseases associated with opioid injection, such as hepatitis and HIV. The Computerized Oral Prescription Administration System (COPATM) device is being developed as an automated oral liquid dispensing system. COPA is specifically designed to deliver liquid oral controlled and non-controlled medications to the validated Intended User. While the need for COPA began with an opioid epidemic with adverse consequences that have escalated in the last two decades, an even more urgent need for a take-home device supporting opioid use disorder (OUD) patients emerged at the onset of the COVID-19 pandemic. The pandemic has limited access to methadone maintenance therapy/treatment at opioid treatment programs in both urban and rural sections of the US. The COPA device has a major application to at-home methadone maintenance treatment, based upon the device's innovative dual biometric confirmation of both the patient's fingerprint and dentition before delivery of drug. We propose to design, engineer and human factor test an enhanced COPA prototype and submit it for FDA De Novo approval.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2024	BERKSHIRE BIOMEDICAL CORPORATION	5950 BERKSHIRE LN	DALLAS	TX	75225	DALLAS	USA	Drug Use and Addiction Research Programs	000	3	1/8/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $371,510 )
2024	2024	BERKSHIRE BIOMEDICAL CORPORATION	5950 BERKSHIRE LN	DALLAS	TX	75225	DALLAS	USA	Drug Use and Addiction Research Programs	001	3	2/12/2024	SUPPLEMENT FOR EXPANSION	$149,650
2024	2024	BERKSHIRE BIOMEDICAL CORPORATION	5950 BERKSHIRE LN	DALLAS	TX	75225	DALLAS	USA	Drug Use and Addiction Research Programs	000	3	12/21/2023	NON-COMPETING CONTINUATION	$221,860
2024	2022	BERKSHIRE BIOMEDICAL CORPORATION	5950 BERKSHIRE LN	DALLAS	TX	75225	DALLAS	USA	Drug Use and Addiction Research Programs	002	1	4/29/2024	NEW	$0
														Subtotal = $371,510

Issue Date FY: 2023 ( Subtotal = $1,564,357 )
2023	2023	BERKSHIRE BIOMEDICAL CORPORATION	5950 BERKSHIRE LN STE 375	DALLAS	TX	75225	DALLAS	USA	Drug Use and Addiction Research Programs	000	2	11/30/2022	EXTENSION WITH OR WITHOUT FUNDS	$1,564,357
														Subtotal = $1,564,357

Issue Date FY: 2022 ( Subtotal = $266,048 )
2022	2022	BERKSHIRE BIOMEDICAL CORPORATION	5950 BERKSHIRE LN STE 375	DALLAS	TX	75225	DALLAS	USA	Drug Use and Addiction Research Programs	000	1	7/19/2022	NEW	$266,048
														Subtotal = $266,048

Grand Total All Awards = $2,201,915

Top

All Categories

About

Search

Reports

Data Submission

Award Information

COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing

Award Number: R44DA057185

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2022

PERIOD OF PERFORMANCE END DATE: 07/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer